Cargando…

Alzheimer’s Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy – Bridging the Missing Link

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease worldwide. With the increasing trend of population aging, the estimated number of AD continues to climb, causing enormous medical, social and economic burden to the society. Currently, no drug is available to cure the disease o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Jingqiong, Wang, Xiaochuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859419/ https://www.ncbi.nlm.nih.gov/pubmed/35197824 http://dx.doi.org/10.3389/fncel.2021.811852

Ejemplares similares

Inflamma-MicroRNAs in Alzheimer’s Disease: From Disease Pathogenesis to Therapeutic Potentials
por: Liang, Yuanyuan, et al.
Publicado: (2021)

All roads lead to heterogeneity: The complex involvement of astrocytes and microglia in the pathogenesis of Alzheimer’s disease
por: St-Pierre, Marie-Kim, et al.
Publicado: (2022)

Noradrenergic Modulation of the Piriform Cortex: A Possible Avenue for Understanding Pre-Clinical Alzheimer’s Disease Pathogenesis
por: Rajani, Vishaal, et al.
Publicado: (2022)

Inflammation Spreading: Negative Spiral Linking Systemic Inflammatory Disorders and Alzheimer’s Disease
por: Ni, Junjun, et al.
Publicado: (2021)

Hebbian plasticity: the elusive missing link at the heart of Alzheimer’s disease pathogenesis?
por: Jeans, Alexander F.
Publicado: (2022)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
por: Zhang, Guimei, et al.
Publicado: (2021)

Neuronal Damage and Neuroinflammation, a Bridge Between Bacterial Meningitis and Neurodegenerative Diseases
por: Farmen, Kristine, et al.
Publicado: (2021)

Editorial: Hearing Loss: From Pathogenesis to Treatment
por: He, Zuhong, et al.
Publicado: (2022)

Microglial Immunometabolism in Alzheimer’s Disease
por: Shippy, Daniel C., et al.
Publicado: (2020)

Microvascular Alterations in Alzheimer's Disease
por: Steinman, Joe, et al.
Publicado: (2021)

Editorial: Mesenchymal Stromal Cell Therapy for Regenerative Medicine
por: Capilla-González, Vivian, et al.
Publicado: (2022)

Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson’s Disease
por: Han, Deqiang, et al.
Publicado: (2020)

Establishment of a Novel Fetal Growth Restriction Model and Development of a Stem-Cell Therapy Using Umbilical Cord-Derived Mesenchymal Stromal Cells
por: Kitase, Yuma, et al.
Publicado: (2020)

Editorial: Hearing loss: from pathogenesis to treatment, volume II
por: Zou, Shengyu, et al.
Publicado: (2023)

Application of adipose-derived mesenchymal stem cells in an in vivo model of peripheral nerve damage
por: González-Cubero, Elsa, et al.
Publicado: (2022)

Neuroprotective Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells From Different Donors on Spinal Cord Injury in Mice
por: Zhu, Xu, et al.
Publicado: (2022)

Unsuspected Involvement of Spinal Cord in Alzheimer Disease
por: Lorenzi, Roberta Maria, et al.
Publicado: (2020)

Astrocytic Propagation of Tau in the Context of Alzheimer's Disease
por: Fleeman, Rebecca M., et al.
Publicado: (2021)

Editorial: Emerging Mechanisms in Neuronal Signaling: From Cell Biology to Pathogenesis
por: Guido, Mario Eduardo, et al.
Publicado: (2020)

Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
por: Perdigão, Catarina, et al.
Publicado: (2020)

Type-I Interferons in Alzheimer's Disease and Other Tauopathies
por: Sanford, Sophie A. I., et al.
Publicado: (2022)

GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
por: Toral-Rios, Danira, et al.
Publicado: (2020)

Perspectives on ROCK2 as a Therapeutic Target for Alzheimer’s Disease
por: Weber, Audrey J., et al.
Publicado: (2021)

Prostacyclin Promotes Degenerative Pathology in a Model of Alzheimer’s Disease
por: Womack, Tasha R., et al.
Publicado: (2022)

Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease
por: García, Octavio, et al.
Publicado: (2022)

Alzheimer’s disease like neuropathology in Down syndrome cortical organoids
por: Zhao, Helen H., et al.
Publicado: (2022)

Activity-dependent oligodendrocyte calcium dynamics and their changes in Alzheimer’s disease
por: Yoshida, Kenji, et al.
Publicado: (2023)

Targeting dopamine transporter to ameliorate cognitive deficits in Alzheimer's disease
por: Shaikh, Ammara, et al.
Publicado: (2023)

Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer’s Disease
por: Luo, Shen, et al.
Publicado: (2020)

Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
por: Liu, Jun-Lin, et al.
Publicado: (2018)

The Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review
por: Hulshof, Lianne A., et al.
Publicado: (2022)

SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease
por: Zhao, Yuhai, et al.
Publicado: (2022)

Editorial: Linking Neuroinflammation and Glial Phenotypic Changes in Neurological Diseases
por: Tang, Yu, et al.
Publicado: (2019)

Editorial: Common Pathways Linking Neurodegenerative Diseases—The Role of Inflammation
por: Kujawska, Małgorzata, et al.
Publicado: (2021)

The Role of Inflammation and Infection in Age-Related Neurodegenerative Diseases: Lessons From Bacterial Meningitis Applied to Alzheimer Disease and Age-Related Macular Degeneration
por: Too, Lay Khoon, et al.
Publicado: (2021)

Brain-Derived Neurotrophic Factor Is an Important Therapeutic Factor in Mesenchymal Stem Cell Secretions for Treatment of Traumatic Peripheral Pelvic Injuries
por: Yuan, Xiaoyi, et al.
Publicado: (2022)

The “Loss” of Perineuronal Nets in Alzheimer's Disease: Missing or Hiding in Plain Sight?
por: Scarlett, Jarrad M., et al.
Publicado: (2022)

Estrogen, Cognitive Performance, and Functional Imaging Studies: What Are We Missing About Neuroprotection?
por: Marchant, Ivanny Carolina, et al.
Publicado: (2022)

Novel therapeutic approach to slow down the inflammatory cascade in acute/subacute spinal cord injury: Early immune therapy with lipopolysaccharide enhanced neuroprotective effect of combinational therapy of granulocyte colony-stimulating factor and bone-marrow mesenchymal stem cell in spinal cord injury
por: Hashemizadeh, Shiva, et al.
Publicado: (2022)

Synaptic Organizers in Alzheimer’s Disease: A Classification Based on Amyloid-β Sensitivity
por: Lee, Alfred Kihoon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n3jibqgelp3l0mbk23ek3jh83c